
1. Westmorland MG, Williams RM, Amick BC III, Shannon H, Rasheed F. Disability management practices in Ontario workplaces: employees' perceptions. Disabil Rehabil. 2005;27:825-35.
https://doi.org/10.1080/09638280400020631
 
2. Solstad Vedeler J, Schreuer N. Policy in action: stories on the workplace accommodation process. J Disabil Policy Stud. 2011;22:95-105.
https://doi.org/10.1177/1044207310395942
 
3. Medin J, Barajas J, Ekberg K. Stroke patients' experiences of return to work. Disabil Rehabil. 2006;28:1051-60.
https://doi.org/10.1080/09638280500494819
 
4. Lock S, Jordan L, Bryan K, Maxim J. Work after stroke: focusing on barriers and enablers. Disabil Soc. 2005;20:33-47.
https://doi.org/10.1080/0968759042000283629
 
5. Gold PB, Oire SN, Fabian ES, Wewiorski NJ. Negotiating reasonable workplace accommodations: perspectives of employers, employees with disabilities, and rehabilitation service providers. J Vocat Rehab. 2012;37:25-37.
https://doi.org/10.3233/JVR-2012-0597
 
6. Dyck I, Jongbloed L. Women with multiple sclerosis and employment issues: a focus on social and institutional environments. Can J Occup Ther. 2000;67:337-46.
https://doi.org/10.1177/000841740006700506
 
7. de Jonge DM, Rodger SA. Consumer-identified barriers and strategies for optimizing technology use in the workplace. Disabil Rehabil: Assist Technol. 2006;1:79-88.
https://doi.org/10.1080/09638280500167324
 
8. Crooks VA. Women's experiences of developing musculoskeletal diseases: employment challenges and policy recommendations. Disabil Rehabil. 2007;29:1107-16.
https://doi.org/10.1080/09638280600948193
 
9. Yelin E, Sonneborn D, Trupin L. The prevalence and impact of accommodations on the employment of persons 51-61 years of age with musculoskeletal conditions. Arthritis Care Res. 2000;13:168-76.
https://doi.org/10.1002/1529-0131(200006)13:3<168::AID-ANR6>3.0.CO;2-R
 
10. Radford K, Phillips J, Drummond A, Sach T, Walker M, Tyerman A, Haboubi N, Jones T. Return to work after traumatic brain injury: cohort comparison and economic evaluation. Brain Inj. 2013;27:507-20.
https://doi.org/10.3109/02699052.2013.766929
 
11. Allaire SH, Li W, LaValley MP. Reduction of job loss in persons with rheumatic diseases receiving vocational rehabilitation. Arthritis Rheum. 2003;48:3212-8.
https://doi.org/10.1002/art.11256
 
 
Do not use your browser's 'BACK' button.
Use the 'RESET' button to submit more references.

We now provide space to match 1,000 references per submission

To learn about other services and interfaces see our MetaData Delivery page.

Please contact us if you have any questions.

Tips:
There should be no line breaks within an individual reference.
When submitting multiple references they must be in alphabetical order or presented as a numbered list.
To check the accuracy of a reference, click on the link that is returned with the reference.
You may use any reference style, although it works best if references are formatted in a consistent and standard style. Just cut and paste this example list to try it out:
1. Boucher RC (2004) New concepts of the pathogenesis of cystic fibrosis lung disease. Eur Resp J 23: 146–158.
2. Knowles MR, Boucher RC (2002) Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Investig 109: 571–577.
3. Antunes MB, Cohen NA (2007) Mucociliary clearance - a critical upper airway host defense mechanism and methods of assessment. Curr Opin Allergy Clin Immunol 7: 5–10.
4. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, et al. (1989) Identification of the Cystic-Fibrosis Gene - Cloning and Characterization of Complementary-Dna. Science 245: 1066–1072.
5. Rommens JM, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, et al. (1989) Identification of the Cystic-Fibrosis Gene - Chromosome Walking and Jumping. Science 245: 1059–1065.
6. Bobadilla JL, Macek M, Fine JP, Farrell PM (2002) Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening. Human Mutation 19: 575–606.
7. Qu BH, Thomas PJ (1996) Alteration of the cystic fibrosis transmembrane conductance regulator folding pathway - Effects of the Delta F508 mutation on the thermodynamic stability and folding yield of NBD1. J Biol Chem 271: 7261–7264.

